Bristol-Myers Squibb Company (NYSE:BMY) is holding above the stock’s moving averages, indicating a postitive uptrend for Healthcare company.
Scanning the equity markets, it is quite obvious that there are plenty of stocks to choose from. This may make things a bit overwhelming for the beginner investor, but it should also be seen as a great opportunity. Of course, studying up on every single stock may be nearly impossible. Just focusing in on a few different stocks at a time that pique the interest may be the way to start. Investors are often bombarded with stock picking strategies and sure bet winners. Some of the information might end up being correct, but a lot of it may turn out to be nonsense. If investors decide to manage their own money, they may want to make sure that no stone is left unturned. Doing the proper amount of research can work wonders for the health of a portfolio over the course of time. Following a proven market guru may work for some, but it may leave others with many questions that have gone unanswered. What works for one investor may not work for another.
In order to tell which way a stock is trending, the stock’s share price should be compared to its moving average. The stock will be uptrending if it is being traded above its moving averages and downtrending if it is being traded below. The stock stands -2.24% away from its 50-day simple moving average and -11.45% away from the 200-day average. The price currently stands at $47.01.
Let’s take a look at how the stock has been performing recently. Over the past twelve months, Bristol-Myers Squibb Company (NYSE:BMY)‘s stock was -9.56%. -6.39% over the last quarter, and -8.45% for the past six months.
Over the past 50 days,